Loading...
1ISG-020 Market access in the eu, do we have enough evidence?
BACKGROUND: The European Medicines Agency (EMA) is responsible for the scientific evaluation of medicines for use in the European Union (EU), providing a scientific opinion on the granting of EU-wide marketing authorisations. PURPOSE: We conducted a retrospective analysis of new active substances (N...
Na minha lista:
| Udgivet i: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535274/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.20 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|